Article
mRNA based vaccines provide broad protection against different SARS-CoV-2 variants of concern
23 May 2022
Abstract excerpt
In order to overcome the pandemic of COVID-19, messenger RNA (mRNA)-based vaccine has been extensively researched as a rapid and versatile strategy. Herein, we described the immunogenicity of mRNA-based vaccines for Beta and the most recent Omicron variants. The homologous mRNA-Beta and mRNA-Omicron and heterologous Ad5-nCoV plus mRNA vaccine exhibited high-level cross-reactive neutralization for Beta, original,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
